The New York Times, May 27, 2015. The Federal Bureau of Investigation has begun looking into whether medical device makers, doctors and hospitals broke the law by failing to report problems linked to a power tool used during gynecologic surgery, according to two people who said they were interviewed by investigators.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Cur is Crowdfunding a Medical Device That isn’t Cleared by the FDA, and That’s a Problem
The Verge, May 14, 2015. A company called Cur is developing a promising new pain-relieving product, according to Mashable, Fast Company, and PC World. Problem is, the company is doing it by launching a $50,000 crowdfunding campaign on its own website prior to filing for the necessary FDA clearance. The move could doom the product before it ever hits the market — or it could point to a glaring loophole in FDA regulations.
Read More »Long-Term Data on Complications Adds to Criticism of Contraceptive Implant
The New York Times, May 3, 2015. When a new contraceptive implant came on the market over a decade ago, it was considered a breakthrough for women who did not want to have more children, a sterilization procedure that could be done in a doctor’s office in just 10 minutes.
Read More »Bill to Speed Approvals for Drugs Is Cut Back
The New York Times, April 30, 2015. Legislation that would have accelerated the pace of federal drug approvals in a way that critics said threatened to erode patient safety was formally released this week, in a scaled-back version with many of the most controversial provisions left out.
Read More »Diet Drug Companies Spent $60 Million Since 2010 Amid Push to Win FDA Approval for New Products
Journal Sentinel, April 19, 2015. In the months before the U.S. Food and Drug Administration did an about-face on diet drugs, agency officials participated in a series of meetings at George Washington University.
Read More »